KemOn, Stock Price 4,075 KRW.. Down -11.8% Compared to Previous Day
KemOne ranked among the top searched stocks on 2 days in the past month.
As of 12:30 PM on the 4th, KemOne is trading at 4,075 KRW, down 11.8% from the previous day. This is a 33.61% increase compared to October 23. KemOne is known as Korea's first non-clinical CRO company.
Over the past 5 days, individual investors have sold a net 356,391 shares, while foreigners and institutions have bought a net 519,149 shares and sold a net 149,021 shares, respectively.
On November 3, KemOne became an issue in the market with the news that 'SK Bioscience will start domestic production of the COVID-19 vaccine in January next year...'
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051414165763158_1778735817.jpg)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- [Breaking] Park Sukeun, Central Labor Relations Commission Chair: "Some Gaps Narrowed Between Samsung Electronics Labor and Management"
- Is This the Peak? As Others Hesitate..."The Answer Is Clear for Surviving the KOSPI 10,000 Era"
- "If That's the Case, Why Not Just Buy Stocks?" ETFs in Name Only, Now 'Semiconductor-Heavy' and a Playground for Short-Term Traders
- "No Cure Available, Spread Accelerates... Already 105 Dead, American Infected"
※Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
